AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2025
Nov 5, 2025
35134_dirs_2025-11-05_8bb7af4f-f825-44d9-9aa7-54fcc0cd87de.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2025-11-03
Reporting Person: Walker Marlan D (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-03 | Non-Qualified Stock Option (right to buy) | $1.15 | A | 67492 | Acquired | 2035-11-03 | Common Stock (67492) | Direct |
Footnotes
F1: Underlying shares each vested on November 3, 2025.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16